Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

Abstract Background Few data are available regarding the use of direct antiviral agents (DAAs) for chronic hepatitis C in psychiatric patients. The aim of the study is to assess safety and outcome of DAAs in patients with psychiatric comorbidities. Methods This retrospective, observational, single-c...

Full description

Bibliographic Details
Main Authors: Nicolò de Gennaro, Lucia Diella, Laura Monno, Gioacchino Angarano, Michele Milella, Annalisa Saracino
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Infectious Diseases
Subjects:
HCV
Antiviral treatment
SVR
Psychiatric comorbidity
Online Access:http://link.springer.com/article/10.1186/s12879-020-4922-2

Internet

http://link.springer.com/article/10.1186/s12879-020-4922-2

Similar Items